IP Library Granted Patent US 9,034,642
Granted Patent B2
US 9,034,642 · App. 14/151,227 · Granted May 19, 2015

Genes of an otitis media isolate of nontypeable

Inventors: Lauren O. Bakaletz (Hilliard, OH); Robert S. Munson, Jr. (Columbus, OH); David W. Dyer (Oklahoma City, OK)
Assignees: NATIONWIDE CHILDREN'S HOSPITAL; THE BOARD OF REGENTS OF UNIVERSITY OF OKLAHOMA
C07K16/1242A61K39/00C07K14/285A61K39/102
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,034,642
App. No.
14/151,227
Granted
May 19, 2015
Kind
B2
Abstract

The invention relates to the polynucleotide sequence of a nontypeable strain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and/or the nasopharynx.

Claims (7)

1. A viral vector comprising an isolated polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1498.

2. A vector comprising an isolated polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1498 wherein the vector is operatively linked to an expression control sequence.

3. An isolated host cell comprising the vector of claim 1 or 2 .

4. A method for detecting NTHi bacteria in a biological sample comprising:

(a) contacting an isolated polynucleotide comprising the nucleotide sequence set forth in SEQ ID NO: 1498 with a biological sample under stringent hybridization conditions, wherein the stringent hybridization conditions comprise washing with 0.015 M sodium chloride, 0.0015 M sodium citrate at 65-68° C., and

(b) detecting hybridization of the polynucleotide within the sample, wherein hybridization indicates the presence of NTHi bacteria in the biological sample.

5. The method of claim 4 wherein the biological sample is selected from the group consisting of serum, sputum, ear fluid, blood, urine, lymphatic fluid, and cerebrospinal fluid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2014
From: BAKALETZ, LAUREN O.; MUNSON, ROBERT S., JR.
To: NATIONWIDE CHILDREN'S HOSPITAL
Reel/Frame 034163/0186 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2014
From: DYER, DAVID W.
To: THE BOARD OF REGENTS OF UNIVERSITY OF OKLAHOMA
Reel/Frame 034163/0441 →
Continuity (4)
Division 13612176 · Sep 12, 2012
Division 11917368
Provisional Application 60691214 · Jun 16, 2005
Related Publication 20140127221A1 · May 8, 2014